SIRT1 and metabolic dysfunction-associated steatotic liver disease: In obese mice, adipocytes and liver cells accumulate excess lipid, which inhibits the activity of Sirt1 and AMPK, inactivating the Sirt1/AMPK pathway and aggravating the development of NAFLD [16].